11.57
0.61%
0.07
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
0.11%
37.14
|
37.10 | 21.62 | 27.38 | 17.05 |
Operating Expenses
|
3.54%
324.67
|
313.56 | 298.04 | 261.54 | 395.13 |
Interest Income/Expense |
2.13%
9.444
|
9.247 | 8.912 | - | - |
Benefits Costs and Expenses |
1,489%
-5,061.20
|
364.46 | 347.72 | 206.59 | 399.13 |
Costs And Expenses |
1,489%
-5,061.20
|
364.46 | 347.72 | 206.59 | 399.13 |
Operating Income/Loss |
1,931%
5,060.88
|
-276.45 | -276.41 | -234.17 | -378.08 |
Income/Loss From Continuing Operations Before Tax |
1,657%
5,098.34
|
-327.36 | -326.09 | -179.22 | -382.08 |
Income Tax Expense/Benefit |
583.31%
25.67
|
3.757 | 1.752 | -3.793 | 2.819 |
Income/Loss From Continuing Operations After Tax |
1,632%
5,072.66
|
-331.12 | -327.85 | -175.42 | -384.90 |
Net Income/Loss
|
1,632%
5,072.66
|
-331.12 | -327.85 | -60.86 | -384.90 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
12.21%
-23.52
|
-26.79 | -36.03 | -27.25 | -32.88 |
Basic Average Shares |
3.94%
800.59
|
770.23 | 759.27 | 9.7363 | 713.32 |
Diluted Average Shares |
9.64%
844.46
|
770.23 | 759.27 | 9.7363 | 713.32 |
Basic Earnings Per Share |
1,692%
6.37
|
-0.40 | -0.38 | -0.03 | -0.49 |
Diluted Earnings Per Share |
1,608%
6.03
|
-0.40 | -0.38 | -0.03 | -0.49 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):